SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:lnu-9785"
 

Search: onr:"swepub:oai:DiVA.org:lnu-9785" > Design, synthesis, ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Design, synthesis, and characterization of a single-chain peptide antagonist for the relaxin-3 receptor RXFP3

Haugaard-Kedström, Linda M. (author)
Linnéuniversitetet,Institutionen för naturvetenskap, NV
Shabanpoor, Fazel (author)
Florey Neuroscience, The University of Melbourne
Hossain, Mohammed Akhter (author)
Florey Neuroscience, The University of Melbourne
show more...
Clark, Richard (author)
The University of Queensland, Institute for Molecular Bioscience
Ryan, Philip (author)
Florey Neuroscience, The University of Melbourne
Craik, David (author)
The University of Queensland, Institute for Molecular Bioscience
Gundlach, Andrew (author)
Florey Neuroscience, The University of Melbourne
Wade, John (author)
Florey Neuroscience, The University of Melbourne
Bathgate, Ross (author)
Florey Neuroscience, The University of Melbourne
Rosengren, K. Johan (author)
Linnéuniversitetet,Institutionen för naturvetenskap, NV,BBCL
show less...
 (creator_code:org_t)
2011-03-08
2011
English.
In: Journal of the American Chemical Society. - : American Chemical Society (ACS). - 0002-7863 .- 1520-5126. ; 133:13, s. 4965-4974
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Relaxin-3 is a two-chain disulfide-rich peptide that is the ancestral member of the relaxin peptide family and, together with its G protein-coupled receptor RXFP3, is highly expressed in the brain. Strong evolutionary conservation of relaxin-3 suggests a critical biological function and recent studies have demonstrated modulation of sensory, neuroendocrine, metabolic, and cognitive systems. However, detailed studies of central relaxin-3-RXFP3 signaling have until now been severely hampered by the lack of a readily available high-affinity antagonist for RXFP3. Previous studies have utilized a complex two-chain chimeric relaxin peptide, R3(B Delta 23-27)R/I5, in which a truncated relaxin-3 B-chain carrying an additional C-terminal Arg residue was combined with the insulin-like peptide S (INSL5) A-chain. In this study we demonstrate that, by replacing the native Cys in this truncated relaxin-3 B-chain with Ser, a single-chain linear peptide of 23 amino acids that retains high-affinity antagonism for RXFP3 can be achieved. In vivo studies demonstrate that this peptide, R3 B1-22R, antagonized relaxin-3/RXFP3 induced increases in feeding in rats after intracerebroventricular injection. Thus, R3 B1-22R represents an excellent tool for biological studies probing relaxin pharmacology and a lead molecule for the development of synthetically tractable, single-chain RXFP3 modulators for clinical use.

Subject headings

NATURVETENSKAP  -- Kemi (hsv//swe)
NATURAL SCIENCES  -- Chemical Sciences (hsv//eng)

Keyword

Biokemi
Biochemistry

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view